Pharmaceuticals 2012, 5(5), 417-446; doi:10.3390/ph5050417
Review

Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors

 and * email
Received: 3 February 2012; in revised form: 18 April 2012 / Accepted: 19 April 2012 / Published: 27 April 2012
(This article belongs to the Special Issue GPCR Based Drug Discovery)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: G-protein coupled receptors (GPCRs) are cell surface proteins responsible for translating >80% of extracellular reception to intracellular signals. The extracellular information in the form of neurotransmitters, peptides, ions, odorants etc is converted to intracellular signals via a wide variety of effector molecules activating distinct downstream signaling pathways. All GPCRs share common structural features including an extracellular N-terminal, seven-transmembrane domains (TMs) linked by extracellular/intracellular loops and the C-terminal tail. Recent studies have shown that most GPCRs function as dimers (homo- and/or heterodimers) or even higher order of oligomers. Protein-protein interaction among GPCRs and other receptor proteins play a critical role in the modulation of receptor pharmacology and functions. Although ~50% of the current drugs available in the market target GPCRs, still many GPCRs remain unexplored as potential therapeutic targets, opening immense possibility to discover the role of GPCRs in pathophysiological conditions. This review explores the existing information and future possibilities of GPCRs as tools in clinical pharmacology and is specifically focused for the role of somatostatin receptors (SSTRs) in pathophysiology of diseases and as the potential candidate for drug discovery.
Keywords: somatostatin; somatostatin receptors; heterodimerization; G proteins; GPCRs; Pb-FRET
PDF Full-text Download PDF Full-Text [533 KB, uploaded 27 April 2012 10:21 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Somvanshi, R.K.; Kumar, U. Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors. Pharmaceuticals 2012, 5, 417-446.

AMA Style

Somvanshi RK, Kumar U. Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors. Pharmaceuticals. 2012; 5(5):417-446.

Chicago/Turabian Style

Somvanshi, Rishi K.; Kumar, Ujendra. 2012. "Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors." Pharmaceuticals 5, no. 5: 417-446.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert